EGFR and cancer: To further investigate whether the action of 3l in suppressing cancer cell proliferation was related to the EGFR-TK pathway, surface plasmon resonance (SPR) experiments were carried out to study the interaction of 3l and icotinibwith wild-type EGFR proteins.